Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
U.S. health officials want to force pharmaceutical companies to disclose the prices of their products in television advertisements, setting up a clash with drugmakers who see the move as impinging free speech.
Health care experts widely expected the Affordable Care Act to hobble Medicare Advantage, the government-funded private health plans that millions of seniors have chosen as an alternative to original Medicare.
The nation's second-largest health insurer has agreed to pay the government a record $16 million to settle potential privacy violations in the biggest known health care hack in U.S. history, officials said Monday.
Lots of state elected officials run for higher office, and most of them lose. Steve Poizner is one example; he served one term as the state insurance commissioner before running for governor in 2010, getting trounced by Meg Whitman in the Republican primary.
Small Business Owners say that the most important issue affecting them is the cost of health care, according to the National Small Business Association’s annual Politics of Small Business Survey.
California is the first state to legislatively prohibit some of its residents from taking advantage of a Trump administration rule that expanded access to small business health plans.
Premiums for a popular type of "silver" health plan under the Affordable Care Act will edge downward next year in most states, the Trump administration's health chief announced Thursday.
Autoworkers in this blue-collar, central Indiana city have an eager helper waiting to pick up the bill at their next doctor visit.
President Donald Trump has repeatedly condemned U.S. immigration policy, arguing that many immigrants pose a threat to the nation and drain U.S. resources. But a study released Monday about health insurance challenges the president’s portrayal.
David Herzberg was alarmed when he heard that Richard Sackler, former chairman of opioid giant Purdue Pharma, was listed as an inventor on a new patent for an opioid addiction treatment.